These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 35964931)

  • 21. Treatment of two infants with PIK3CA-related overgrowth spectrum by alpelisib.
    Morin G; Degrugillier-Chopinet C; Vincent M; Fraissenon A; Aubert H; Chapelle C; Hoguin C; Dubos F; Catteau B; Petit F; Mezel A; Domanski O; Herbreteau G; Alesandrini M; Boddaert N; Boutry N; Broissand C; Han TK; Branle F; Sarnacki S; Blanc T; Guibaud L; Canaud G
    J Exp Med; 2022 Mar; 219(3):. PubMed ID: 35080595
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-hotspot PIK3CA mutations are more frequent in CLOVES than in common or combined lymphatic malformations.
    Brouillard P; Schlögel MJ; Homayun Sepehr N; Helaers R; Queisser A; Fastré E; Boutry S; Schmitz S; Clapuyt P; Hammer F; Dompmartin A; Weitz-Tuoretmaa A; Laranne J; Pasquesoone L; Vilain C; Boon LM; Vikkula M
    Orphanet J Rare Dis; 2021 Jun; 16(1):267. PubMed ID: 34112235
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Somatic frameshift mutation in PIK3CA causes CLOVES syndrome by provoking PI3K/AKT/mTOR pathway.
    Yan W; Zhang B; Wang H; Mo R; Jiang X; Qin W; Ma L; Lin Z
    Hereditas; 2021 Jun; 158(1):18. PubMed ID: 34074347
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alpelisib for treatment of patients with PIK3CA-related overgrowth spectrum (PROS).
    Canaud G; Lopez Gutierrez JC; Irvine AD; Vabres P; Hansford JR; Ankrah N; Branle F; Papadimitriou A; Ridolfi A; O'Connell P; Turner S; Adams DM
    Genet Med; 2023 Dec; 25(12):100969. PubMed ID: 37634128
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Undergrowth Of First Toe In PiK3CA-Related Overgrowth Spectrum (PROS).
    Triana P; Sarmiento MDC; Rodriguez-Laguna L; Martinez-Glez V; Lopez-Gutierrez JC
    Ann Vasc Surg; 2023 Jan; 88():233-238. PubMed ID: 35878698
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Complex vascular anomalies and tissue overgrowth of limbs associated with increased skin temperature and peripheral venous dilatation: parks weber syndrome or PROS?
    Su LX; Sun Y; Wang Z; Wang D; Yang X; Zheng L; Wen M; Fan X; Cai R
    Hereditas; 2022 Jan; 159(1):1. PubMed ID: 34980271
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical and genetic analyses of patients with lateralized overgrowth.
    Kim YM; Lee Y; Choi Y; Choi IH; Heo SH; Choi JM; Do HS; Jang JH; Yum MS; Yoo HW; Lee BH
    BMC Med Genomics; 2022 Sep; 15(1):206. PubMed ID: 36175890
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Overgrowth Syndromes Caused by Somatic Variants in the Phosphatidylinositol 3-Kinase/AKT/Mammalian Target of Rapamycin Pathway.
    Akgumus G; Chang F; Li MM
    J Mol Diagn; 2017 Jul; 19(4):487-497. PubMed ID: 28502730
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CLOVES syndrome: review of a PIK3CA-related overgrowth spectrum (PROS).
    Martinez-Lopez A; Blasco-Morente G; Perez-Lopez I; Herrera-Garcia JD; Luque-Valenzuela M; Sanchez-Cano D; Lopez-Gutierrez JC; Ruiz-Villaverde R; Tercedor-Sanchez J
    Clin Genet; 2017 Jan; 91(1):14-21. PubMed ID: 27426476
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phenotypic and molecular characterization of five patients with PIK3CA-related overgrowth spectrum (PROS).
    Gökpınar İli E; Taşdelen E; Durmaz CD; Altıner Ş; Tuncalı T; Martinez-Glez V; Karabulut HG; Vural S; Ceylaner S; Acar MO; Ilgın Ruhi H
    Am J Med Genet A; 2022 Jun; 188(6):1792-1800. PubMed ID: 35238469
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lateralized overgrowth with vascular malformation caused by a somatic PTPN11 pathogenic variant: Another piece added to the puzzle of mosaic RASopathies.
    Mussa A; Turchiano A; Cardaropoli S; Coppo P; Pantaleo A; Bagnulo R; Ranieri C; Iacoviello M; Garganese A; Stella A; Vallero SG; Bertin D; Santoro F; Carli D; Ferrero GB; Resta N
    Genes Chromosomes Cancer; 2022 Nov; 61(11):689-695. PubMed ID: 35778969
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro efficacy of ARQ 092, an allosteric AKT inhibitor, on primary fibroblast cells derived from patients with PIK3CA-related overgrowth spectrum (PROS).
    Ranieri C; Di Tommaso S; Loconte DC; Grossi V; Sanese P; Bagnulo R; Susca FC; Forte G; Peserico A; De Luisi A; Bartuli A; Selicorni A; Melis D; Lerone M; Praticò AD; Abbadessa G; Yu Y; Schwartz B; Ruggieri M; Simone C; Resta N
    Neurogenetics; 2018 May; 19(2):77-91. PubMed ID: 29549527
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vascular malformations syndromes: an update.
    Martinez-Lopez A; Salvador-Rodriguez L; Montero-Vilchez T; Molina-Leyva A; Tercedor-Sanchez J; Arias-Santiago S
    Curr Opin Pediatr; 2019 Dec; 31(6):747-753. PubMed ID: 31693582
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeted therapy in patients with PIK3CA-related overgrowth syndrome.
    Venot Q; Blanc T; Rabia SH; Berteloot L; Ladraa S; Duong JP; Blanc E; Johnson SC; Hoguin C; Boccara O; Sarnacki S; Boddaert N; Pannier S; Martinez F; Magassa S; Yamaguchi J; Knebelmann B; Merville P; Grenier N; Joly D; Cormier-Daire V; Michot C; Bole-Feysot C; Picard A; Soupre V; Lyonnet S; Sadoine J; Slimani L; Chaussain C; Laroche-Raynaud C; Guibaud L; Broissand C; Amiel J; Legendre C; Terzi F; Canaud G
    Nature; 2018 Jun; 558(7711):540-546. PubMed ID: 29899452
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Updates on Diagnosis and Treatment of PIK3CA-Related Overgrowth Spectrum.
    Chen H; Gao W; Liu H; Sun B; Hua C; Lin X
    Ann Plast Surg; 2023 May; 90(5S Suppl 2):S209-S215. PubMed ID: 36729078
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Response to Alpelisib in Clinically Distinct Pediatric Patients With PIK3CA -related Disorders.
    Kolitz E; Fernandes NJ; Agim NG; Ludwigl K
    J Pediatr Hematol Oncol; 2022 Nov; 44(8):482-485. PubMed ID: 35129141
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical pitfalls in the diagnosis of segmental overgrowth syndromes: a child with the c.2740G > A mutation in PIK3CA gene.
    Maguolo A; Antoniazzi F; Spano A; Fiorini E; Gaudino R; Mauro M; Cantalupo G; Biban P; Maitz S; Cavarzere P
    Ital J Pediatr; 2018 Sep; 44(1):110. PubMed ID: 30231930
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Papillary Intralymphatic Angioendothelioma in a Child With
    Debelenko L; Mansukhani MM; Remotti F
    Pediatr Dev Pathol; 2023; 26(2):166-171. PubMed ID: 36775953
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diffuse capillary malformation with overgrowth contains somatic PIK3CA variants.
    Goss JA; Konczyk DJ; Smits P; Sudduth CL; Bischoff J; Liang MG; Greene AK
    Clin Genet; 2020 May; 97(5):736-740. PubMed ID: 31909475
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Somatic PIK3CA mutations in seven patients with PIK3CA-related overgrowth spectrum.
    Yeung KS; Ip JJ; Chow CP; Kuong EY; Tam PK; Chan GC; Chung BH
    Am J Med Genet A; 2017 Apr; 173(4):978-984. PubMed ID: 28328134
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.